Therefore, the researchers suggest discontinuing daprodustat to reduce the risk of recurrent ischemic strokes. Hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitors are ...

With a market cap of $2.67 billion, Geron Corporation (GERN) is a small-cap, commercial-stage biopharmaceutical company ...

An expert discussed the findings of the COMMANDS trial evaluating Reblozyl’s role in red blood cell transfusion independence ...

With FDA approval for imetelstat and solid financials, Geron shows great promise in MDS treatment. Read more on GERN stock ...